CONTACT US   |  (864) 397-5101

SCbioDrive

Accelerator for Emerging Life Sciences Companies

In Partnership With

How It Works

During this eight-week hybrid program, we connect you with:

  • Six industry-specific curriculum modules led by experts
  • A small, dedicated group of industry mentors tailored to fit your needs
  • Networking opportunities and industry connections:
    • End-of-program Demo Day, where you’ll present your company to a curated group who can take your company to the next level
    • 1:1 targeted partnering opportunities meeting(s) with life sciences leaders
    • A $2,000 stipend to cover Demo Day travel expenses
 

Inaugural Cohort Program Timeline

  • Application Deadline: June 28
  • Accepted Companies Notified: Week of August 26
  • Accelerator Start Date: September 23
  • In-Person Demo Days: November 18-21

How You Benefit

Through our partnership with MassBio, SCbioDrive companies will experience complete a program model with proven success and be able to:

  • Access a large network of venture capitalist through SCbio and Massbio associations.
  • Participate in select MassbioDrive events and Demo Days, increasing your visibility to potential investors.

Applicant Qualifications

You’re eligible to apply for SCbioDrive if:

  • You have a therapeutic that you believe can become the next big biotech startup
  • Your startup has access to the intellectual property for your science or technology, either through a license agreement or through an option agreement to negotiate a license agreement
  • Your startup has raised less than $2 million in equity-based funding
  • You will be able to participate in all cornerstone components of the program (curriculum, weekly mentoring sessions, and networking events)
SCBio Drive Logo Color Horizontal FINAL

SCbioDrive is an accelerator program designed to advance emerging companies through expert business curricula industry guidance and mentorship.

A biannual program, SCbioDrive will select up to six seed-stage therapeutics companies for an eight-week course, consisting of seven weeks of virtual instruction followed by one week in person at SCbio facilities in Charleston, S.C.

Company founders will complete industry-specific curriculum modules, led by experts from leading companies. Each cohort will conclude with an in-person Demo Day.

What You Will Learn

Commercialization

Deloitte for Website

Regulatory

Intellectual Property & Legal

Maynard Nexsen for Website

Operations

Fundraising

Announcing Soon!

Drug Discovery

Announcing Soon!

Want To Become A Mentor?

Mentors play an invaluable role in helping SCbioDrive companies grow and develop. 

Join The Inaugural Cohort

Advance your company through expert business curricula, industry guidance, and mentorship.

FAQs and
Contacts

If you have any questions, check out our FAQs or contact the SCBio team.

Sign Up For Accelerator Updates

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.